Looking ahead to November’s election, trade policy forms a core fixture for both parties. Both the GOP and Democratic Party have expressed support for tariffs with a common set of objectives in mind: to ensure the global competitiveness of American goods while forestalling unfair trade practices perpetrated by the Chinese government and captive firms. 

One such area that cannot be overlooked in this discussion is the development and production of critical pharmaceutical products.

Recommended Stories

Trump administration urged to take on China’s ‘Pharma Death Grip’

China’s assault on our economy is being funded by the US taxpayer

To solve drug prices, we need more competition, not more government meddling